Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase III HIMALAYA study

  • Vogel, A.; 
  • Chan, S. L.; 
  • Furuse, J.; 
  • Tak, W. Y.; 
  • Masi, G.; 
  • 외 9명
Citations

WEB OF SCIENCE

2
제목
Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase III HIMALAYA study
저자
Vogel, A.; Chan, S. L.; Furuse, J.; Tak, W. Y.; Masi, G.; Varela, M.; Kim, J. H.; Tanasanvimon, S.; Monzon, M. E. Reig; Dayyani, F.; Makowsky, M.; Marcovitz, M.; Negro, A.; Abou-Alfa, G. K.
DOI
10.1016/j.annonc.2022.10.115
발행일
2022-11
유형
Meeting Abstract
저널명
Annals of Oncology
권
33
페이지
S1463 ~ S1464